Last updated on February 2019

A Rollover Study to Provide Continued Treatment With Eltrombopag


Brief description of study

This study will provide continued access to treatment with eltrombopag for subjects who are currently participating in a GlaxoSmithKline (GSK) sponsored investigational study of eltrombopag (parent study) and to collect long term safety data.

Clinical Study Identifier: NCT01957176

Find a site near you

Start Over